To further develop an already existing Nurse Clinic model at Kaiser Permanente Riverside, researchers in this study developed an internal specialized diabetes training program using the American Association of Diabetes Educators and American Diabetes Association guidelines to improve effectiveness.
To further develop an already existing Nurse Clinic model at Kaiser Permanente Riverside, researchers in this study developed an internal specialized diabetes training program using the American Association of Diabetes Educators and American Diabetes Association guidelines to improve effectiveness. Ten, 3-hour training sessions were delivered to registered nurses over the course of 10 months in 5 clinics. Nurses engaged in face-to-face visits with patients as well as phone follow-ups for up to 8 weeks or until the patient had achieved glycemic goal. Some of the barriers and topics that nurses faced were medication adherence strategies, self-management skills, and lipid and hypertension management.
Not only were the glycemic control rate outcomes improved across all 5 clinics from 5% to 11%, but the impact that the refined Nurse Clinic model had on financial outcomes was improved as well. Researchers noted that the usual cost per patient is estimated to be $202/physician visit, whereas the nurse visit equated to approximately $30 per face-to-face visit and $20 per follow-up phone call. Additionally, the authors of the study noted that a department survey showed a 92% provider satisfaction with the training provided, and that “the specialized diabetes training program further enhanced the value of clinical outcomes in a patient-centered medical home."
To read more about this study, please visit the American Diabetes Association’s website.
Technology Takes Center Stage at the 2025 AAD Annual Meeting
March 14th 2025The role of artificial intelligence, DataDerm, and telehealth in advancing dermatology care was discussed throughout the meeting, with experts highlighting their potential regarding patient access and health equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More
Late-Breaking Antiviral Session Features Phase 3 Results on Efficacy of Doravirine/Islatravir
March 13th 2025The combination of doravirine plus islatravir was noninferior to bictegravir/emtricitabine/tenofovir alafenamide and oral antiretroviral therapy in patients who switched to doravirine plus islatravir.
Read More